[Antidepressive therapy of neurodermatitis in atopic subjects].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000008:administration & dosage / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000627:therapeutic use*; D002980:Climate; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D011537:Pruritus / Q000188:drug therapy; D011602:Psychophysiologic Disorders / Q000209:etiology
D010919:Placebos; D000639:Amitriptyline; D002707:Chlordiazepoxide
Zur antidepressiven Therapie bei der atopischen konstitutionellen Neurodermitis.